BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33313608)

  • 1. [Pathological diagnosis, work-up and reporting of breast cancer. Recommendations from the 4th Breast Cancer Consensus Conference].
    Cserni G; Francz M; Járay B; Kálmán E; Kovács I; Krenács T; Tóth E; Udvarhelyi N; Vass L; Vörös A; Kulka J
    Magy Onkol; 2020 Dec; 64(4):301-328. PubMed ID: 33313608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological diagnosis, work-up and reporting of breast cancer. Recommendations of the 3rd Hungarian Consensus Conference on Breast Cancer].
    Cserni G; Kulka J; Francz M; Járay B; Kálmán E; Kovács I; Krenács T; Udvarhelyi N; Vass L
    Magy Onkol; 2016 Sep; 60(3):209-28. PubMed ID: 27579721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
    Cserni G; Francz M; Járay B; Kálmán E; Kovács I; Krenács T; Tóth E; Udvarhelyi N; Vass L; Vörös A; Krivokuca A; Kajo K; Kajová Macháleková K; Kulka J
    Pathol Oncol Res; 2022; 28():1610373. PubMed ID: 35845921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
    Mátrai Z; Kelemen P; Kósa C; Maráz R; Paszt A; Pavlovics G; Sávolt Á; Simonka Z; Tóth D; Kásler M; Kaprin A; Krivorotko P; Vicko F; Pluta P; Kolacinska-Wow A; Murawa D; Jankau J; Ciesla S; Dyttert D; Sabol M; Zhygulin A; Avetisyan A; Bessonov A; Lázár G
    Pathol Oncol Res; 2022; 28():1610377. PubMed ID: 35783360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of imaging methods in the current screening, diagnostics and treatment of breast cancer - Professional guidelines. 3rd Breast Cancer Consensus Meeting].
    Forrai G; Ambrózay É; Bidlek M; Borbély K; Kovács E; Lengyel Z; Ormándi K; Péntek Z; Riedl E; Sebõ É; Szabó É
    Magy Onkol; 2016 Sep; 60(3):181-93. PubMed ID: 27579719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiology/Nuclear Medicine Group. Use of imaging methods in the current screening, diagnostics and treatment of breast cancer - Professional guidelines. 4th Breast Cancer Consensus Conference].
    Forrai G; Kovács E; Ambrózay É; Barta M; Borbély K; Lengyel Z; Ormándi K; Péntek Z; Tasnádi T; Sebő É
    Magy Onkol; 2020 Dec; 64(4):278-299. PubMed ID: 33313607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recommendations of the 2nd Breast Cancer Consensus Conference (Kecskemét, November 8-9, 2009) -- Introduction].
    Kásler M
    Magy Onkol; 2010 Sep; 54(3):209. PubMed ID: 20870597
    [No Abstract]   [Full Text] [Related]  

  • 9. [3rd Hungarian Breast Cancer Consensus Conference - Surgery Guidelines].
    Lázár G; Bursics A; Farsang Z; Harsányi L; Kósa C; Maráz R; Mátrai Z; Paszt A; Pavlovics G; Tamás R
    Magy Onkol; 2016 Sep; 60(3):194-207. PubMed ID: 27579720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic therapy of breast cancer: practice guideline].
    Horváth Z; Boér K; Dank M; Kahán Z; Kocsis J; Kövér E; Pajkos G; Pikó B; Rubovszky G; Eckhardt S
    Magy Onkol; 2016 Sep; 60(3):241-57. PubMed ID: 27579723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D
    J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
    Rubovszky G; Kocsis J; Boér K; Chilingirova N; Dank M; Kahán Z; Kaidarova D; Kövér E; Krakovská BV; Máhr K; Mriňáková B; Pikó B; Božović-Spasojević I; Horváth Z
    Pathol Oncol Res; 2022; 28():1610383. PubMed ID: 35898593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference Participants.
    Hammond ME; Fitzgibbons PL; Compton CC; Grignon DJ; Page DL; Fielding LP; Bostwick D; Pajak TF
    Arch Pathol Lab Med; 2000 Jul; 124(7):958-65. PubMed ID: 10888771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
    Kim JY; Lim JE; Jung HH; Cho SY; Cho EY; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
    Breast Cancer Res Treat; 2018 Oct; 171(3):737-745. PubMed ID: 29931426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 cases.
    Liu ZH; Wang K; Lin DY; Xu J; Chen J; Long XY; Ge Y; Luo XL; Zhang KP; Liu YH; Xu FP
    Breast Cancer Res Treat; 2019 May; 175(1):51-57. PubMed ID: 30712197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer.
    Guo L; Yuan P; Zhang J; Ling Y; Li W; Zhao B; Ying J; Xuan L
    Breast Cancer Res Treat; 2017 Nov; 166(1):77-84. PubMed ID: 28712009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The updated 2018 American Society of Clinical Oncology/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in situ hybridization groups.
    Woo JW; Lee K; Chung YR; Jang MH; Ahn S; Park SY
    Hum Pathol; 2020 Apr; 98():10-21. PubMed ID: 32027910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology.
    Field AS; Raymond WA; Rickard M; Arnold L; Brachtel EF; Chaiwun B; Chen L; Di Bonito L; Kurtycz DFI; Lee AHS; Lim E; Ljung BM; Michelow P; Osamura RY; Pinamonti M; Sauer T; Segara D; Tse G; Vielh P; Chong PY; Schmitt F
    Acta Cytol; 2019; 63(4):257-273. PubMed ID: 31112942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.